South Park Quicktimes

Are you going to speed? New technique



For Mr. Joseph Plesio
Are you an anxious person often passes speed? Would you like to relax a little and do not know how?, Well the French Institute of anxiety and stress of life defined rules according to experts, if we could put into practice 10 of them, we could have a good quality of life, do share some of them?
Some of the rules which they say would help us manage stress and enjoy more of life are:
1) Plan your day and leave space for the unexpected and for what it is gratifying.
2) Learn to say no without feeling guilty try to do all that we ask for is a huge attrition.
3) Focus on one task at a time, are more agile than your mental pictures, you also get tired.
4) Forget that you are indispensable, all you can keep walking without his action saved yourself.
5) Separate the imaginary from the real problems, separate them and remove them because they are in a mental space needed for more important things.
6) You will recall that the rigidity is good for stones but harmful to humans.
7) Do not try to find out if you spoke ill of you, do not beat yourself up to criticism, just watch what you speak well of you but believe it However, you are worth what he is not what they say. Interesting
true, might have forgotten all this, but pay attention to these last 3 and will be sufficient.
8) Remember to have someone you trust and talk openly, did you think a friend or a friend? Maybe, but do not forget a friend, the most reliable, always listening to the prayers of his children.
9) You are not infallible nor omnipotent, so every time you need ask for help, ask the right people without forgetting where the best help can come, see?
10) Finally, the biblical Psalmist wrote - "Trust in God and do good, loves the Lord and He will fulfill your deepest desires, put your life in God's hands, trust Him and He will come to your aid "

Baby Schedule 13 Months

cancer: train



Scientists are testing a new technique to fight cancer "train" blood cells learn to attack tumors.



The procedure is being studied by researchers at the Cancer Institute Dana-Farber, Boston, USA.
involves taking a blood sample from the patient, remove the lymphocytes (a type of white blood cells) and "convincing" in the laboratory for memorize and learn how to fight cancer cells.

Subsequently, these cells "educated", called T-tumor, is injected into the patient again and begin to hunt and destroy cancer cells.

As expressed by researchers in the journal Science Translational Medicine (Translational Medicine), preliminary tests showed that T cells were able to stay in the bloodstream for more than a year.

And in some cases, they say, there was no need to refer patients to other cancer treatments, which are highly toxic.


antitumor T cells in the laboratory trained can induce long-term anti-cancer effects. The dream is that we create a pool of anti-tumor T cells can be generated quickly for the patient, "Dr. Marcus Butler
, Dana-Farber Institute


Long-term effects

experimental technique is being tested in several patients from different countries. And scientists hope that, if proven results, could be available as a treatment in the clinic in about five years.

In the investigation of Dana-Farber Institute, part of Harvard University, participated nine people with melanoma, the deadliest form of cancer skin.

All were in advanced stages of the disease, and the tumor had spread from the skin to other organs.


If caught early, melanoma can usually be cured. But when it spread to other parts of the body, patients rarely survive more than a year.
experimental therapy did not stop the spread of cancer in most patients studied. But one did manage to shrink the tumor and, as researchers say, two years later, he was not in the scanners.

These are only preliminary studies of therapy and still need to test it on a larger number people.


But as the BBC said Dr. Marcus Butler, who led the study, the finding raises the possibility that such treatment may one day be offered to cancer patients.


immunotherapy is being tested with hundreds of patients worldwide

Immunotherapy

The approach, known as adoptive T cell therapy, has only been tested with several hundred people in the world.

One obstacle that presents itself is that the cells tend to disappear rapidly when injected into the patient.


But research Dana-Farber Institute showed that the life of these cells can be extended to prepare in the laboratory with an artificial version of cells found naturally in the immune system.

These cells will "inform" the system that the cancer is present and needs to be destroyed.

According to Dr. Naoto Hirano, another author of the study, the next step will be to study the treatment with other therapies that may increase the number and effectiveness of T cells
"We will begin a series of clinical trials are investigating combinations that work best for patients, "he explains. It's

only one of several investigations being conducted in several countries on these immunotherapy treatments, which, according to experts, are very promising in the fight against cancer.

According to Dr Laura Bell, of the British charity Cancer Research UK, "immunotherapy is a very interesting area of \u200b\u200bcancer research, designed to exploit the power of the body's own immune system to fight cancer."

"The results of laboratory studies in this field are now beginning to be reflected in the clinic, and we will be following your progress with great interest," added the expert.

Source: BBC World

North Face Jacket Petite

cell vaccine tested in humans with pancreatic cancer



More than fifty hospitals in the United Kingdom began the phase of human testing of a vaccine for pancreatic cancer, which has the lowest survival rate.

More than a thousand patients with advanced disease have been incorporated into the draft TeloVac tests.
Although vaccines are commonly associated with infection prevention, in the case of TeloVac, look for a different strategy: to stimulate the immune system to stand up to cancer cells.

The test involves inoculating the vaccine in regular doses While continuing chemotherapy. The results will be compared with those for patients receiving only chemotherapy treatment
The vaccine contains small sections of the protein telomerase, cancer cells produce in large quantities. The aim is to stimulate the immune system to recognize the telomerase present on the surface of cancer cells and thus attack the tumor.

Professor John Neoptolemos, Royal Liverpool University Hospital, one of the coordinators of the tests, said: "The problem is that tumors are intelligent and can become immune cells that help protect them traitors."

"The vaccine gets rid of the masking effect of the tumor," said Neoptolemos



Worse
survival rate for pancreatic cancer has the worst survival rate of all the most common forms of the disease. Only three out of every hundred patients survive five years or more. Rhona

Longworth, 43, was diagnosed in February. "For someone who never smoked and hardly drank, was a huge impact."


"I have the hope that the vaccine works and that I am a person who will live happily and healthily after this."

Joan Roberts, 69, keeps his fingers crossed while says that the vaccine appears to have few side effects.

"I am satisfied that remains stable and has not grown. You have to be positive," he said.

TeloVac tests have funds of the charity Cancer Research UK, which supports studies against various cancers, and is

using vaccines or antibodies.

TeloVac is not a cure
The manufacturer of the vaccine, Kael-GemVax South Korea plans to test a new vaccine for lung cancer later, using the same technology.

Last year, the first therapeutic vaccine against cancer came to U.S. market as a treatment for prostate cancer.

Phase 3 or final TeloVac tests should produce results within a year.

Cancer Research UK notes that the vaccine has just begun to be tested in humans will not represent a cure, but if it works, could serve to prolong the patient's life
Source: BBC World